BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19577713)

  • 1. Prokineticin receptors in cardiovascular function: foe or friend?
    Nebigil CG
    Trends Cardiovasc Med; 2009 Feb; 19(2):55-60. PubMed ID: 19577713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.
    Boulberdaa M; Urayama K; Nebigil CG
    Cardiovasc Res; 2011 Nov; 92(2):191-8. PubMed ID: 21856786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation.
    Urayama K; Guilini C; Turkeri G; Takir S; Kurose H; Messaddeq N; Dierich A; Nebigil CG
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):841-9. PubMed ID: 18421008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prokineticins and the heart: diverging actions elicited by signalling through prokineticin receptor-1 or -2.
    Attramadal H
    Cardiovasc Res; 2009 Jan; 81(1):3-4. PubMed ID: 19008213
    [No Abstract]   [Full Text] [Related]  

  • 6. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis.
    Urayama K; Guilini C; Messaddeq N; Hu K; Steenman M; Kurose H; Ert G; Nebigil CG
    FASEB J; 2007 Sep; 21(11):2980-93. PubMed ID: 17442730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic inactivation of prokineticin receptor-1 leads to heart and kidney disorders.
    Boulberdaa M; Turkeri G; Urayama K; Dormishian M; Szatkowski C; Zimmer L; Messaddeq N; Laugel V; Dollé P; Nebigil CG
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):842-50. PubMed ID: 21273561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bv8/Prokineticin proteins and their receptors.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells.
    Keramidas M; Faudot C; Cibiel A; Feige JJ; Thomas M
    J Endocrinol; 2008 Mar; 196(3):473-82. PubMed ID: 18310443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine properties of prokineticins.
    Monnier J; Samson M
    FEBS J; 2008 Aug; 275(16):4014-21. PubMed ID: 18647349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokineticins: novel mediators of inflammatory and contractile pathways at parturition?
    Catalano RD; Lannagan TR; Gorowiec M; Denison FC; Norman JE; Jabbour HN
    Mol Hum Reprod; 2010 May; 16(5):311-9. PubMed ID: 20172976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bv8/Prokineticins and their Receptors A New Pronociceptive System.
    Negri L; Lattanzi R; Giannini E; Canestrelli M; Nicotra A; Melchiorri P
    Int Rev Neurobiol; 2009; 85():145-57. PubMed ID: 19607967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle.
    Battersby S; Critchley HO; Morgan K; Millar RP; Jabbour HN
    J Clin Endocrinol Metab; 2004 May; 89(5):2463-9. PubMed ID: 15126578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
    Chen J; Kuei C; Sutton S; Wilson S; Yu J; Kamme F; Mazur C; Lovenberg T; Liu C
    Mol Pharmacol; 2005 Jun; 67(6):2070-6. PubMed ID: 15772293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prokineticin-signaling pathway.
    Ngan ES; Tam PK
    Int J Biochem Cell Biol; 2008; 40(9):1679-84. PubMed ID: 18440852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer.
    Jiang X; Abiatari I; Kong B; Erkan M; De Oliveira T; Giese NA; Michalski CW; Friess H; Kleeff J
    Pancreatology; 2009; 9(1-2):165-72. PubMed ID: 19077468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system.
    Negri L; Lattanzi R
    Curr Opin Pharmacol; 2012 Feb; 12(1):62-6. PubMed ID: 22136937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration.
    Guilini C; Urayama K; Turkeri G; Dedeoglu DB; Kurose H; Messaddeq N; Nebigil CG
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H844-52. PubMed ID: 20023120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.
    Hoffmann P; Feige JJ; Alfaidy N
    Placenta; 2007 Oct; 28(10):1049-58. PubMed ID: 17531315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss.
    Su MT; Lin SH; Lee IW; Chen YC; Hsu CC; Pan HA; Kuo PL
    Hum Reprod; 2010 Nov; 25(11):2923-30. PubMed ID: 20847187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.